Please enable JavaScript to continue using this application.

Compare $HURA vs $INO | Chartloom

Compare

$HURA vs $INO

TuHURA Biosciences Inc · Inovio Pharmaceuticals Inc

HURA

TuHURA Biosciences Inc

INO

Inovio Pharmaceuticals Inc

Compare $HURA vs $INO

Comparing TuHURA Biosciences Inc and Inovio Pharmaceuticals Inc

HURATuHURA Biosciences Inc

INOInovio Pharmaceuticals Inc

HURATuHURA Biosciences Inc

Market cap

$125M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

161.3%

52W performance

-24.9%

FCF yield

-24.0%

INOInovio Pharmaceuticals Inc

Market cap

$95M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.48x

Rev growth (TTM)

-100.0%

YTD performance

-32.0%

52W performance

-55.1%

FCF yield

-85.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HURA

INO

Detailed metrics comparison

HURA

TuHURA Biosciences Inc

INO

Inovio Pharmaceuticals Inc

Market Cap

HURA$125M

INO$95M

Enterprise Value

HURA$127M

INO$63M

Price

HURA$1.96

INO$1.15

P/E Ratio

HURAN/A

INON/A

P/S Ratio

HURA0.00x

INO423.69x

EV/Sales

HURA0.00x

INO312.32x

EV/EBITDA

HURA0.00x

INO0.00x

P/B Ratio

HURA6.58x

INO27.44x

P/FCF Ratio

HURAN/A

INON/A

EV/FCF

HURA-4.26x

INO-0.78x

PEG Ratio

HURAN/A

INON/A

Forward P/E (NTM)

HURAN/A

INON/A

Forward P/S (NTM)

HURAN/A

INO2.48x

Revenue (TTM)

HURA$0

INO$0

Revenue Growth (YoY)

HURAN/A

INO-100.0%

Forward Rev Growth

HURA197.3%

INO7491.0%

Gross Margin (TTM)

HURA0.0%

INO58.9%

Operating Margin (TTM)

HURA0.0%

INO0.0%

EBITDA Margin (TTM)

HURA0.0%

INO0.0%

Net Margin (TTM)

HURA0.0%

INO0.0%

FCF Margin (TTM)

HURAN/A

INON/A

Net Income (TTM)

HURA$-31M

INO$-67M

FCF (TTM)

HURA$-30M

INO$-81M

EPS (TTM)

HURA-$0.48

INO-$0.83

ROE (TTM)

HURA-15427.0%

INO-19050.0%

ROA (TTM)

HURA-10698.0%

INO-11105.0%

ROIC (TTM)

HURA-14636.0%

INO-19050.0%

Cash

HURA$996K

INO$32M

Debt

HURA$4M

INO$0

Net Cash/Debt

HURA$-3M

INO$32M

Current Ratio (TTM)

HURA0.18x

INO1.00x

Quick Ratio (TTM)

HURA0.16x

INO0.92x

Debt/Equity (TTM)

HURA0.19x

INO0.00x

Debt/Assets (TTM)

HURA0.0%

INO0.0%

Interest Coverage (TTM)

HURAN/A

INON/A

Net Debt/EBITDA (TTM)

HURA0.00x

INO0.00x

Beta

HURA-0.24

INO1.68

52W Performance

HURA-24.9%

INO-55.1%

YTD Performance

HURA161.3%

INO-32.0%

% from 52W High

HURA-42.9%

INO-57.7%

% from 52W Low

HURA378.0%

INO104.2%

Asset Turnover (TTM)

HURA0.00x

INO0.00x

FCF Yield (TTM)

HURA-24.0%

INO-85.4%

Earnings Yield (TTM)

HURA-24.5%

INO-71.3%

Dividend Yield (TTM)

HURA0.0%

INON/A

Rule of 40

HURA0.0

INO-100.0

EV/GP/RG

HURAN/A

INON/A

Ticker research

View HURA research View INO research

Metric	HURA TuHURA Biosciences Inc	INO Inovio Pharmaceuticals Inc
Market & Valuation
Market Cap	$125M	$95M
Enterprise Value	$127M	$63M
Price	$1.96	$1.15
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	423.69x
EV/Sales	0.00x	312.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.58x	27.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.26x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.48x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	197.3%	7491.0%
Profitability
Gross Margin (TTM)	0.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-67M
FCF (TTM)	$-30M	$-81M
EPS (TTM)	-$0.48	-$0.83
ROE (TTM)	-15427.0%	-19050.0%
ROA (TTM)	-10698.0%	-11105.0%
ROIC (TTM)	-14636.0%	-19050.0%
Financial Health
Cash	$996K	$32M
Debt	$4M	$0
Net Cash/Debt	$-3M	$32M
Current Ratio (TTM)	0.18x	1.00x
Quick Ratio (TTM)	0.16x	0.92x
Debt/Equity (TTM)	0.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.24	1.68
52W Performance	-24.9%	-55.1%
YTD Performance	161.3%	-32.0%
% from 52W High	-42.9%	-57.7%
% from 52W Low	378.0%	104.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.0%	-85.4%
Earnings Yield (TTM)	-24.5%	-71.3%
Dividend Yield (TTM)	0.0%	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View HURA research	View INO research

Valuation

P/S Ratio

HURA

0.00x

INO

423.69x

EV/FCF

HURA

-4.26x

INO

-0.78x

Growth & revenue

Revenue Growth TTM

INO

-100.0%

Forward Revenue Growth

INO

7491.0%

HURA

197.3%

Profitability & performance

Gross Margin

INO

58.9%

HURA

0.0%

ROE

HURA

-15427.0%

INO

-19050.0%

FCF Yield %

HURA

-24.0%

INO

-85.4%

52-Week Performance

HURA

-24.9%

INO

-55.1%

Detailed metrics comparison

HURA

TuHURA Biosciences Inc

INO

Inovio Pharmaceuticals Inc

Market Cap

HURA$125M

INO$95M

Enterprise Value

HURA$127M

INO$63M

Price

HURA$1.96

INO$1.15

P/E Ratio

HURAN/A

INON/A

P/S Ratio

HURA0.00x

INO423.69x

EV/Sales

HURA0.00x

INO312.32x

EV/EBITDA

HURA0.00x

INO0.00x

P/B Ratio

HURA6.58x

INO27.44x

P/FCF Ratio

HURAN/A

INON/A

EV/FCF

HURA-4.26x

INO-0.78x

PEG Ratio

HURAN/A

INON/A

Forward P/E (NTM)

HURAN/A

INON/A

Forward P/S (NTM)

HURAN/A

INO2.48x

Revenue (TTM)

HURA$0

INO$0

Revenue Growth (YoY)

HURAN/A

INO-100.0%

Forward Rev Growth

HURA197.3%

INO7491.0%

Gross Margin (TTM)

HURA0.0%

INO58.9%

Operating Margin (TTM)

HURA0.0%

INO0.0%

EBITDA Margin (TTM)

HURA0.0%

INO0.0%

Net Margin (TTM)

HURA0.0%

INO0.0%

FCF Margin (TTM)

HURAN/A

INON/A

Net Income (TTM)

HURA$-31M

INO$-67M

FCF (TTM)

HURA$-30M

INO$-81M

EPS (TTM)

HURA-$0.48

INO-$0.83

ROE (TTM)

HURA-15427.0%

INO-19050.0%

ROA (TTM)

HURA-10698.0%

INO-11105.0%

ROIC (TTM)

HURA-14636.0%

INO-19050.0%

Cash

HURA$996K

INO$32M

Debt

HURA$4M

INO$0

Net Cash/Debt

HURA$-3M

INO$32M

Current Ratio (TTM)

HURA0.18x

INO1.00x

Quick Ratio (TTM)

HURA0.16x

INO0.92x

Debt/Equity (TTM)

HURA0.19x

INO0.00x

Debt/Assets (TTM)

HURA0.0%

INO0.0%

Interest Coverage (TTM)

HURAN/A

INON/A

Net Debt/EBITDA (TTM)

HURA0.00x

INO0.00x

Beta

HURA-0.24

INO1.68

52W Performance

HURA-24.9%

INO-55.1%

YTD Performance

HURA161.3%

INO-32.0%

% from 52W High

HURA-42.9%

INO-57.7%

% from 52W Low

HURA378.0%

INO104.2%

Asset Turnover (TTM)

HURA0.00x

INO0.00x

FCF Yield (TTM)

HURA-24.0%

INO-85.4%

Earnings Yield (TTM)

HURA-24.5%

INO-71.3%

Dividend Yield (TTM)

HURA0.0%

INON/A

Rule of 40

HURA0.0

INO-100.0

EV/GP/RG

HURAN/A

INON/A

Ticker research

View HURA research View INO research

Metric	HURA TuHURA Biosciences Inc	INO Inovio Pharmaceuticals Inc
Market & Valuation
Market Cap	$125M	$95M
Enterprise Value	$127M	$63M
Price	$1.96	$1.15
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	423.69x
EV/Sales	0.00x	312.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.58x	27.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.26x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	2.48x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	197.3%	7491.0%
Profitability
Gross Margin (TTM)	0.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-67M
FCF (TTM)	$-30M	$-81M
EPS (TTM)	-$0.48	-$0.83
ROE (TTM)	-15427.0%	-19050.0%
ROA (TTM)	-10698.0%	-11105.0%
ROIC (TTM)	-14636.0%	-19050.0%
Financial Health
Cash	$996K	$32M
Debt	$4M	$0
Net Cash/Debt	$-3M	$32M
Current Ratio (TTM)	0.18x	1.00x
Quick Ratio (TTM)	0.16x	0.92x
Debt/Equity (TTM)	0.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.24	1.68
52W Performance	-24.9%	-55.1%
YTD Performance	161.3%	-32.0%
% from 52W High	-42.9%	-57.7%
% from 52W Low	378.0%	104.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.0%	-85.4%
Earnings Yield (TTM)	-24.5%	-71.3%
Dividend Yield (TTM)	0.0%	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View HURA research	View INO research